Moving Forward
We will train an ML model to predict the thermostability of Fab sequences. This will be incorporated into AbacusTM to help assess the developability of potential therapeutics for our clients.
Abacus, our own suite of computational tools, leverages structure models, sequence information, and AI to guide and speed up biologic development.
